Treatment of reactive arthritis with infliximab
Abdelmoula, L.C.; Yahia, C.B.H.; Testouri, N.; Tekaya, R.; Ben M'barek, R.; Chaabouni, L.; Zouari, R.
La Tunisie Medicale 86(12): 1095-1097
2008
ISSN/ISBN: 0041-4131 PMID: 19213526 Document Number: 621976
Document emailed within 1 workday
Related Documents
Labarca, Cán.; Massardo, L.; García, P.I.; Jacobelli, S. 2003: Effectiveness of infliximab in patients with inflammatory arthritis refractory to conventional treatment Revista Medica de Chile 131(10): 1157-1164Kiortsis, D.N.; Mavridis, A.K.; Filippatos, T.D.; Vasakos, S.; Nikas, S.N.; Drosos, A.A. 2006: Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 33(5): 921-923
Havel, J.; Aboutalebi, S.; Doughty, L.; Wirges, M. 2008: Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab Journal of Drugs in Dermatology: Jdd 7(8): 796-798
Yazici, Y.; McMorris, B.J.; Darkow, T.; Rosenblatt, L.C. 2009: Patient and physician perception of the infusion process of the biologic agents abatacept, infliximab, and rituximab for the treatment of rheumatoid arthritis Clinical and Experimental Rheumatology 27(6): 907-913
Pachot, A.; Arnaud, Béatrice.; Marrote, H.; Cazalis, M-Angélique.; Diasparra, J.; Gouraud, A.; Mougin, B.; Miossec, P. 2007: Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response Journal of Rheumatology 34(11): 2158-2161
Grigor'eva, V.D.; Barnatskiĭ, V.V. 1997: Reactive arthritis and its treatment with physical factors Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 39-41
Ashmarin, I.I.; Naĭdenov, I.N.; Serebrianskiĭ, I.E.; Zabrodskiĭ, V.V.; Bekrenev, I.P. 1989: Experience with the comprehensive examination and treatment of patients with reactive urogenous arthritis Vestnik Dermatologii i Venerologii 1: 57-60
Samuel, M.P.; Zwillich, S.H.; Thomson, G.T.; Alfa, M.; Orr, K.B.; Brittain, D.C.; Miller, J.R.; Phillips, P.E. 1995: Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritis Journal of Rheumatology 22(10): 1947-1952
2007: Infliximab: new indication. Psoriatic arthritis: just another intravenous me-too drug Prescrire International 16(91): 188
Huppertz, H.I.; Scheurlen, W. 1991: Salmonella septic arthritis presenting as reactive arthritis Journal of Rheumatology 18(7): 1112-1113
Godinho, F.; Godfrin, B.; El Mahou, S.; Navaux, F.; Zabraniecki, L.; Cantagrel, A. 2004: Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 22(3): 328-330
Allanore, Y.; Sellam, J.; Batteux, F.; Job Deslandre, C.; Weill, B.; Kahan, A. 2004: Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab Clinical and Experimental Rheumatology 22(6): 756-758
Becker, M.; Rosé, C.D.; McIlvain-Simpson, G. 2004: Niacin-like reaction to infliximab infusion in systemic juvenile rheumatoid arthritis Journal of Rheumatology 31(12): 2529-2530
True, D.G.; Penmetcha, M.; Peckham, S.J. 2002: Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab Journal of Rheumatology 29(7): 1561-1563
Braun, J.; Grolms, M.; Sieper, J. 1994: Three-colour flowcytometric examination of CD4/CD45 subsets reveals no differences in peripheral blood and synovial fluid between patients with reactive arthritis and rheumatoid arthritis Clinical and Experimental Rheumatology 12(1): 17-22
Cancelliere, N.; Barranco, P.; Vidaurrázaga, C.; Benito, D.-M.; Quirce, S. 2011: Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept Journal of Investigational Allergology and Clinical Immunology 21(3): 248-249
Lukina, G.V.; Sigidin, I.A.; Nasonov, E.L. 2009: Clinical experience with infliximab administration in patients with rheumatoid arthritis (according to Russian register data) Terapevticheskii Arkhiv 81(8): 65-69
De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135
Balanescu, A.; Radu, E.; Nat, R.; Regalia, T.; Bojinca, V.; Ionescu, R.; Balanescu, S.; Savu, C.; Predeteanu, D. 2005: Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients International Journal of Clinical Pharmacology Research 25(1): 9-18
Cannioto, Z.; Taddio, A.; Lepore, L.; Zennaro, F. 2008: Atlanto-axial subluxation in a patient with polyarticular juvenile idiopathic arthritis: clinical and radiological response to infliximab Clinical and Experimental Rheumatology 26(4): 704-705